-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Initiates Coverage On Camp4 Therapeutics with Buy Rating, Announces Price Target of $8

Benzinga·10/15/2026 09:58:46
语音播报
Needham analyst Joseph Stringer initiates coverage on Camp4 Therapeutics (NASDAQ:CAMP) with a Buy rating and announces Price Target of $8.